Prime Medicine, Inc. (PRME)

Prime Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	182.48	41.57	187.62	185.42	36.98
Short-Term Investments	7.97	80.09	106.3	84.2	16.35
Cash & Short-Term Investments	190.44	121.67	293.92	269.62	53.33
Cash Growth	56.53%	-58.61%	9.01%	405.59%	516.72%
Prepaid Expenses	6.78	19.06	2.45	0.96	0.07
Other Current Assets	14.67	2.25	0.25	-	-
Total Current Assets	211.89	142.98	296.62	270.58	53.4
Property, Plant & Equipment	71.56	36.6	48.55	15.68	0.6
Other Long-Term Assets	14.06	14.28	15.14	15.6	0.79
Total Assets	297.51	193.85	360.31	301.86	54.78
Accounts Payable	11.35	19.54	4.33	1.44	0.25
Accrued Expenses	11.82	10.23	9.02	36.19	0.74
Short-Term Debt	-	-	-	-	17.52
Current Portion of Leases	3.61	9.28	11.69	7.34	-
Current Unearned Revenue	7.09	-	-	-	-
Other Current Liabilities	4.08	17.38	1.67	13.02	0.93
Total Current Liabilities	37.96	56.42	26.71	57.98	19.44
Long-Term Leases	37.18	4.36	17.05	3.07	-
Long-Term Unearned Revenue	63.22	-	-	-	-
Long-Term Deferred Tax Liabilities	-	-	0.28	1.24	1.87
Other Long-Term Liabilities	6	-	-	-	-
Total Liabilities	144.36	60.78	44.04	62.3	21.31
Common Stock	0	0	0	-	-
Additional Paid-In Capital	840.36	624.41	609.85	15.16	8.35
Retained Earnings	-687.21	-491.33	-293.2	-171.38	-6.01
Comprehensive Income & Other	0	-0.02	-0.38	-0.03	-
Total Common Equity	153.15	133.07	316.27	-156.24	2.34
Shareholders' Equity	153.15	133.07	316.27	239.56	33.47
Total Liabilities & Equity	297.51	193.85	360.31	301.86	54.78
Total Debt	40.79	13.63	28.75	10.41	17.52
Net Cash (Debt)	149.65	108.03	265.18	259.21	35.81
Net Cash Growth	38.52%	-59.26%	2.30%	623.80%	314.17%
Net Cash Per Share	1.26	1.19	7.82	19.98	13.57
Filing Date Shares Outstanding	127.66	115.2	88.4	17.06	24.32
Total Common Shares Outstanding	127.66	92.64	88.36	17.06	24.32
Working Capital	173.93	86.55	269.9	212.6	33.96
Book Value Per Share	1.20	1.44	3.58	-9.16	0.10
Tangible Book Value	153.15	133.07	316.27	-156.24	2.34
Tangible Book Value Per Share	1.20	1.44	3.58	-9.16	0.10
Machinery	29.29	24.16	19.67	5.42	0.64
Construction In Progress	3.58	5.4	1.61	-	-
Leasehold Improvements	5.14	0.58	0.56	0.13	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q